COVID-19 - summaries of key findings on children and young people's views

Children and young people are experiencing the impact of COVID-19, and lockdown, in many ways: their education, access to health services and emotional health and wellbeing. Over the coming weeks, we'll be working with both health professionals and young people (14-24 years old) to look at the evidence from studies looking at their experiences and insights.
Last modified
26 May 2020

To get an email notification of updates to this page, log in and click or tap on the pink button in the grey box above, 'Notify me when updated'.

About these summaries and how they will be developed

In June 2020 RCPCH will work with clinicians to produce research evidence summaries on key themes from the voice and views of children and young people. These will be based on published studies we've identified using our inclusion and exclusion criteria.

Our Children and Young People’s Engagement team will work with young people age 14-24 from RCPCH &Us to help review these studies. The young reviewers will share data, views and themes which stood out for them, which caused concern or surprise, alongside space for their personal narrative or reflection on the data - giving them an opportunity as individuals or as a group to share their views and ideas.

The outputs for their reviews, which we'll publish on this website, might be represented as an infographic, voice note, story piece with testimonial, data summary or other suggestions led by the group.

The young reviewers will also develop a set of questions for policy makers and decision makers to consider in their recovery planning linked to study themes, innovations and priority areas for the College.

Get involved

If you would like to be involved or find out more about our approach, contact and_us@rcpch.ac.uk.

You can also read our summary of the key current evidence regarding COVID-19 in children and young people which is based on published and pre-print studies, and covering topics such as epidemiology. transmission, clinical features and at risk groups.